Platelets: Still a Therapeutical Target for Haemostatic Disorders

Abstract

Platelets are cytoplasmatic fragments from bone marrow megakaryocytes present in blood. In this work, we review the basis of platelet mechanisms, their participation in syndromes and in arterial thrombosis, and their potential as a target for designing new antithrombotic agents. The option of new biotechnological sources is also explored.

Keywords

• platelets
• agonists
• receptor
• thrombosis
• aspirin®